Population pharmacokinetic modeling approach to compare different amikacin dose rates in children with cystic fibrosis: Are we efficient enough?

Jean-Baptiste Woillard

[P25-1-1] Population pharmacokinetic modeling approach to compare different amikacin dose rates in children with cystic fibrosis: Are we efficient enough?

Jean-Baptiste Woillard¹, Stephane Bouchet², Amazigh Lakdhari³, Stephanie Bui⁴, Fanck Saint-Marcoux⁵, Pierre Marquet⁶, Christian Woloch⁷ (1.CHU Limoges, Univ Limoges, 2.CHU Limoges, 3.CHU Limoges, 4.CHU Limoges, 5.CHU Limoges, Univ Limoges, 6.CHU Limoges, Univ Limoges, 7.CHU Limoges)

Keywords:non-parametric, amikacine, cystic fibrosis, PTA

Abstract password authentication.
Password to view abstracts and 'Participants' page is announced on the e-blast sent to early-bird/advanced registrants on September 13. It is also on the page 7 of IATDMCT 2017 PROGRAM BOOK.

Presentation information

[P25-1] P25-1: Anti-infective drugs (1): Aminoglycosides and beta-lactams

[P25-1-1] Population pharmacokinetic modeling approach to compare different amikacin dose rates in children with cystic fibrosis: Are we efficient enough?

Password